Clinical implications of the presence of antibodies to hepatitis C after renal transplantation.
Morales
M
M
Department of Nephrology, Hospital 12 de Octubre, Facultad de Medicina, Universidad Complutense de Madrid, Spain.
Campo
C
C
Castellano
G
G
Colina
F
F
Andres
A
A
Fuertes
A
A
Praga
M
M
Rodicio
J L
JL
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005500:Follow-Up Studies; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000032:analysis*; D018937:Hepatitis C Antibodies; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008111:Liver Function Tests; D008297:Male; D011379:Prognosis; D013256:Steroids / Q000627:therapeutic use
D006508:Hepatitis Antibodies; D018937:Hepatitis C Antibodies; D013256:Steroids; D016572:Cyclosporine; D001379:Azathioprine